News

ALK's ACARIZAX® Receives EU Nod for Treating Children

ALK's ACARIZAX® Receives EU Nod for Treating Children

ALK's ACARIZAX® Gains Approval in Europe for Young Children

ALK (Copenhagen: ALK B) has exciting news regarding its ACARIZAX® (house dust mite sublingual allergy immunotherapy tablet), which has recently received approval from European health authorities. This important milestone allows for the treatment of young children aged five to 11 across 21 EU countries. The company anticipates market introductions soon, with the largest launch happening in Germany.

Significant Research Underpinning the Approval

The foundation of this approval is built on groundbreaking research, particularly the results from the MT-12 clinical trial. This study was the largest ever conducted in pediatric allergy immunotherapy, involving 1,458 young participants from North America and Europe. The randomized, placebo-controlled trial evaluated the safety and efficacy of ACARIZAX® for children suffering from house dust mite-induced allergic rhinitis and conjunctivitis, along with those with asthma. The compelling results of this trial were recently featured in the well-respected journal, The Lancet Regional Health – Europe.

Response from ALK's Leadership

Henriette Mersebach, ALK’s Executive Vice President of R&D, shared her insights on the approval, stating, “Today, most children with allergies rely on treatments for symptom relief, such as antihistamines or steroids. Many still suffer from persistent symptoms and require effective treatments addressing the root causes of their allergies. House dust mite allergies often begin in childhood and are linked to an increased likelihood of developing allergic asthma. This approval is a pivotal moment for enhancing allergy care for children and aligns with ALK’s growth aspirations.”

The Rising Need for Allergy Treatments

Allergies are increasingly common among children, with estimates suggesting that over ten million children between the ages of five and 11 experience uncontrolled respiratory allergies. House dust mites are a prevalent trigger for these allergies and are closely associated with asthma, making effective treatment vital.

Introducing ACARIZAX® and Its Global Availability

In Europe, the house dust mite tablet is known as ACARIZAX®. It is also marketed globally; in the USA, it is called ODACTRA®, while in Japan, it is referred to as MITICURE™. Until now, Japan was the only country with approval for using the tablet in young children, where a significant number of treated patients are indeed youths. Now, the ACARIZAX® tablet is set to serve children aged five to 65 in Europe, subjected to proper clinical history and positive allergen test results, along with existing moderate to severe symptoms despite ongoing treatment with symptom-relief medications. The tablet is also approved for use in adults aged 18-65 with house dust mite-induced allergic asthma.

Future Considerations in Regulatory Approvals

ALK is not stopping here; a regulatory review for ACARIZAX® is ongoing with the US Food and Drug Administration. Additionally, a separate review process for ALK’s ITULAZAX® tree tablet is underway in Europe and Canada, focusing on pediatric use as well. These reviews are projected to conclude around 2025, promising the potential for expanded treatment options in the near future.

Contact Information

For more inquiries about this groundbreaking approval or the treatments, ALK provides several contact points for both media and investor relations. Per Plotnikof represents Investor Relations with contacts at +45 4574 7527 or +45 2261 2525. Additionally, for media inquiries, Maiken Riise Andersen is available at +45 5054 1434.

About ALK

ALK is a prominent global pharmaceutical company specializing in allergy and allergic asthma treatments. With its headquarters in Hørsholm, Denmark, it has around 2,900 employees worldwide and is listed on Nasdaq Copenhagen. ALK aims to improve the lives of those afflicted by allergies, providing a range of allergy immunotherapy (AIT) treatments and related services.

Frequently Asked Questions

What is ACARIZAX®?

ACARIZAX® is a sublingual allergy immunotherapy tablet designed to treat allergies caused by house dust mites in children and adults.

What are the age limits for ACARIZAX® treatment?

ACARIZAX® is approved for use in children aged five to 11 and adults between 18 and 65 years old with diagnosed allergies.

Where is ACARIZAX® approved for use?

ACARIZAX® has received approval in 21 EU countries and is also marketed in the USA and Japan under different names.

What is the significance of the MT-12 trial?

The MT-12 trial provided substantial evidence for the safety and efficacy of ACARIZAX® in children, forming the basis for its approval in Europe.

Who can I contact for more information about ALK's treatments?

For inquiries, you can contact Investor Relations, Per Plotnikof, at +45 4574 7527, or Media Representative, Maiken Riise Andersen, at +45 5054 1434.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 34

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
SAFE Wins Missouri Guard UH-60 Platform Contract Again

Updated Category News Views 30

Helicopter maintenance is one of those businesses where a few feet of floor space can matter more than a glossy brochure full of promises. SAFE Structure Designs has landed a new contract to supply custom wraparound maintenance platforms for UH-60 helicopters at the Missouri Army National Guard facility in Springfield, Missouri. No price was disclosed, no delivery...

Continue Reading
LGT Middle East Win Highlights Patient Private Banking

Updated Category News Views 120

A trophy in Dubai is not a balance sheet, but it can be a useful calling card when the clientele measures relationships in decades rather than quarters. LGT Middle East was named Best Pure Play Private Bank at the WealthBriefing MENA Awards 2026, at a ceremony held in Dubai on November 18. For a family-owned wealth manager working with Middle Eastern families, that sort...

Continue Reading
Dubai's 2028 Fire Congress Puts Global Safety Tech on Stage

Updated Category News Views 77

Fire engines, wildfires, dense towers, and AI are all colliding in Dubai's next big public-safety moment. The World Fire Congress has handed its 2028 host role to Dubai, making this the first time the biennial gathering of global fire and emergency-service leaders will land in the Middle East. That is not a quarterly earnings event, and nobody ought to pretend it is....

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 199

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading
ROHM's GaN PFC Chip Targets the Power-Supply Squeeze

Updated Category News Views 72

Power supplies are where a lot of sleek electronics quietly lose the plot, and ROHM is taking a proper swing at that problem. Its new BM85060FV is a totem-pole power factor correction controller built for gallium nitride, or GaN, high-frequency switching in AC-DC power supplies. The headline is not subtle: ROHM says a 300 to 500 W system using the chip can reach 99%...

Continue Reading
CHN Energy's Indonesia Record Deserves a Hard Look

Updated Category News Views 87

Twenty years of boots sinking into swamp mud tells a sturdier story than a polished anniversary slogan. CHN Energy says it entered Indonesia's energy market two decades ago and has since built an operating presence around reliable electricity, local training and community work. In a country scattered across thousands of islands, dependable power is not some decorative...

Continue Reading
Ajman Forum Puts Algorithmic Messaging Under Scrutiny

Updated Category News Views 53

Algorithms do not merely shuffle posts anymore; they can scramble confidence in the institutions people depend on. That was the serious undercurrent at Ajman Media Forum 2026 – THE SIGNAL, where a session on who leads the government message in an algorithm-driven age brought the discussion back to an uncomfortable reality: communication, cybersecurity and social...

Continue Reading
Makera A1S Tests the Desktop CNC Metal-Cutting Promise

Updated Category News Views 21

Aluminum chips are where desktop-machine marketing stops bluffing, and Makera is leaning right into that test with the A1S. The company opened global pre-orders on November 18 for a machine aimed squarely at the awkward middle ground: users who have outgrown entry-level hobby gear but do not have room, budget, or patience for a full industrial setup. That is a real market...

Continue Reading
Star Catcher Powers a Public-Interest Space Bet Ahead

Updated Category News Views 94

A satellite’s battery budget is a rotten place for humanitarian priorities to die. Common Space and Star Catcher are trying to remove that bottleneck through a partnership that is easy to like on principle and still deserves a clear-eyed look on execution. Common Space, a nonprofit developing an independent, community-governed high-resolution satellite constellation,...

Continue Reading

Top 5 Most Recently Viewed Articles

Gamehaus Holdings Inc. Launches Strategic Share Buyback Plan

Updated Category News Views 222

Gamehaus Holdings Inc. Introduces New Share Repurchase Program Gamehaus Holdings Inc. (Nasdaq: GMHS), a leading mobile game publisher focused on technology, has announced a significant move aimed at returning value to its shareholders. The company has authorized a share repurchase program that allows it to buy back up to US$5 million of its Class A ordinary shares. This...

Continue Reading
AMN Healthcare's Upcoming Earnings Call: What to Expect

Updated Category News Views 191

AMN Healthcare's Upcoming Earnings Conference Call AMN Healthcare Services, Inc. (NYSE: AMN) has announced an important conference call planned for Thursday, November 6, 2025, at 5:00 p.m. Eastern Time. This event aims to provide valuable insights into the company’s third quarter financial results and the outlook for the fourth quarter of the same year. Investors and...

Continue Reading
J&T Express Marks Profit Milestone in 2024 with Strong Growth

Updated Category News Views 520

J&T Express Achieves Profit Milestone Amid Impressive Growth J&T Global Express Limited, commonly known as J&T Express, reported remarkable achievements in its recent annual results, highlighting significant milestones in revenue growth and profitability. In a remarkable development, the company made a substantial leap in the logistics sector, marking its first full-year...

Continue Reading
Innovative Smart Walking Stick Enhances Safety for Users

Updated Category News Views 207

Introducing the Artisan Smart Walking Stick In a world where mobility and safety are paramount, innovation plays a crucial role in enhancing the lives of individuals. The Artisan Smart Walking Stick is a groundbreaking invention emerging from dedicated inventors focused on providing greater independence and safety for users like the elderly and visually impaired. The...

Continue Reading
Golden Ocean Group Limited Announces AGM Resolutions and Results

Updated Category News Views 156

Golden Ocean Group Limited 2025 Annual General Meeting Overview Golden Ocean Group Limited, known by the ticker symbols Oslo:GOGL and Nasdaq:GOGL, recently held its Annual General Meeting (AGM), an essential gathering designed to keep shareholders informed and involved in the company's progress and direction. The meeting showcased the financial health of the organization,...

Continue Reading